ACT Capital Partners
ACT Capital Partners reported 56 stocks worth $152M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are CVX (10.1%), KRYS (9.2%) and TGTX (8.7%).
Latest filing from ACT Capital Partners
Q3 2026This is the first quarter on file for this fund, so there is nothing to compare it with yet.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 1 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  CVX Chevron Corp New | $15.3M | 10.1% | 75K | – | 1 of 1 | |
| 2 |  KRYS Krystal Biotech Inc | $14M | 9.2% | 42K | – | 1 of 1 | |
| 3 |  TGTX TG Therapeutics Inc | $13.2M | 8.7% | 237K | – | 1 of 1 | |
| 4 |  XOM Exxon Mobil Corp | $12.8M | 8.4% | 79K | – | 1 of 1 | |
| 5 |  AMZN Amazon Com Inc | $10.6M | 7.0% | 43K | – | 1 of 1 | |
| 6 |  ABVX Abivax SA | $8.4M | 5.5% | 85K | – | 1 of 1 | |
| 7 |  VKTX Viking Therapeutics Inc | $7.2M | 4.7% | 220K | – | 1 of 1 | |
| 8 |  SKHY SK Hynix Inc Fsponsored ADR 1 ADR Reps 0.1 Ord Shs | $6.4M | 4.2% | 35K | – | 1 of 1 | |
| 9 |  ARWR Arrowhead Pharmaceuticals in | $6.2M | 4.1% | 94K | – | 1 of 1 | |
| 10 |  NKTR Nektar Therapeutics | $5.5M | 3.6% | 90K | – | 1 of 1 |
Positions at Sep 30, 2026, as reported. Change is against the fund's previous filing; weight is the share of the fund's reported stocks.
Options
valued at the underlying shares
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 6, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →ACT Capital Partners 13F FAQ
What does ACT Capital Partners own?
ACT Capital Partners reported 56 stocks worth $152M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are CVX (10.1%), KRYS (9.2%) and TGTX (8.7%). The table above lists every position in the filing (the top 10 without an account).
What did ACT Capital Partners buy and sell in Q3 2026?
This is the first quarter we have for this fund, so there is nothing to compare with yet.
When will ACT Capital Partners file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is ACT Capital Partners's portfolio worth?
The Q3 2026 filing reports $152M in US stocks ($154M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.